Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1967 2
1970 1
1971 1
1973 2
1974 3
1975 1
1976 1
1982 1
1983 2
1985 1
1986 1
1988 1
1989 1
1990 3
1991 1
1993 2
1994 4
1995 1
1996 3
1997 2
1998 5
1999 3
2000 2
2001 6
2002 10
2003 21
2004 23
2005 27
2006 16
2007 29
2008 36
2009 34
2010 47
2011 50
2012 44
2013 44
2014 34
2015 33
2016 44
2017 40
2018 45
2019 52
2020 44
2021 59
2022 46
Text availability
Article attribute
Article type
Publication date

Search Results

762 results
Results by year
Filters applied: . Clear all
Page 1
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial.
Wu XH, Zhu JQ, Yin RT, Yang JX, Liu JH, Wang J, Wu LY, Liu ZL, Gao YN, Wang DB, Lou G, Yang HY, Zhou Q, Kong BH, Huang Y, Chen LP, Li GL, An RF, Wang K, Zhang Y, Yan XJ, Lu X, Lu WG, Hao M, Wang L, Cui H, Chen QH, Abulizi G, Huang XH, Tian XF, Wen H, Zhang C, Hou JM, Mirza MR. Wu XH, et al. Among authors: wu ly. Ann Oncol. 2021 Apr;32(4):512-521. doi: 10.1016/j.annonc.2020.12.018. Epub 2021 Jan 14. Ann Oncol. 2021. PMID: 33453391 Free article. Clinical Trial.
762 results